Concussion Market Forecast Report Outlines Size, Share, And Growth Opportunities Through 2030

 

What Growth Rate And Market Size Expansion Are Predicted For The Concussion Market Across The Forecast Period?
 The concussion market size has grown steadily in recent years. It will grow from $8.2 billion in 2025 to $8.58 billion in 2026 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increasing incidence of sports-related injuries, rising awareness of traumatic brain injuries, expansion of diagnostic imaging availability, growth of rehabilitation services, improved clinical assessment protocols.
 
 The concussion market size is expected to see strong growth in the next few years. It will grow to $10.43 billion in 2030 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing adoption of ai-assisted concussion diagnostics, rising focus on long-term brain health monitoring, expansion of remote patient monitoring solutions, growing investment in neurorehabilitation technologies, increasing demand for personalized concussion management. Major trends in the forecast period include increasing adoption of advanced neuroimaging tools, rising use of digital cognitive assessment platforms, growing integration of wearable monitoring devices, expansion of multidisciplinary rehabilitation approaches, enhanced focus on early and accurate diagnosis.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=11888&type=smp
 
 Which Underlying Drivers Are Influencing The Rapid Growth Of The Concussion Market?
 The rise in the prevalence of neurological diseases is expected to propel the growth of the concussion market going forward. Neurological diseases are a broad category of medical conditions that affect the nervous system, which includes the brain, spinal cord, and peripheral nerves. Neurological diseases, particularly those associated with traumatic brain injuries, often involve concussions as an initiating factor or exacerbating event, contributing to the development, progression, or complications of conditions such as chronic traumatic encephalopathy (CTE) or post-concussion syndrome. For instance, in February 2023, according to the World Health Organization (WHO), a US-based intergovernmental organization, epilepsy, a neurological disease, affects 5 million people globally, with high-income countries seeing 49 per 100,000 cases, while low- and middle-income countries see up to 139 per 100,000. Therefore, the rise in the prevalence of neurological diseases is driving the growth of the concussion market.
 
 What Segmentation Areas Represent Major Opportunities For Expansion In The Concussion Market?
 The concussion market covered in this report is segmented — 
 
 1) By Assessment: Diagnosis, Treatment
 2) By Device: Imaging Devices, Magnetic Resonance Imaging (MRI) Devices, X-Ray, Computed Tomography, Monitoring Devices, Other Devices 
 3) By End User: Hospitals And Clinics, Diagnostic Centers, Medical Camps, Other End-Users
 
 Subsegments:
 1) By Diagnosis: Clinical Assessments, Imaging Techniques 
 2) By Treatment: Pharmacological Treatments, Cognitive Rehabilitation, Physical Therapy
 
 Which Rising Trends Are Anticipated To Influence The Future Trajectory Of The Concussion Market?
 Major companies operating in the concussion market are focusing on developing innovative solutions, such as rapid point-of-care biomarker blood tests, to meet rising demand driven by greater concussion awareness. Rapid point-of-care biomarker blood tests are quick tests performed near the patient that measure specific blood markers to detect or monitor a condition, helping clinicians make immediate decisions about diagnosis, treatment, or further testing. For instance, in April 2024, Abbott Laboratories, a US-based medical device and diagnostics company, launched a whole blood rapid test for traumatic brain injury (TBI) on its portable i-STAT Alinity platform. This test allows clinicians to assess suspected concussions at the patient’s bedside, providing lab-quality results in just 15 minutes. Previously, TBI tests required plasma or serum samples to be sent to a laboratory, but the new clearance enables faster, on-site evaluation, potentially reducing the need for CT scans and improving timely decision-making in urgent care and other healthcare settings. 
 
 Which Leading Players Have A Strong Presence In The Concussion Market?
 Major companies operating in the concussion market are Pfizer Inc., Novartis AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Viatris Inc., Zydus Lifesciences Ltd., Integra LifeSciences Corporation, Nihon Kohden Corporation, Raumedic AG, Lupin Limited, NeuroPace Inc., Compumedics Limited, NeuroLogica Corporation, Neural Analytics Inc., NovaSignal Corp., Back Bay Life Science Advisors, BrainScope Company Inc., Neuro Kinetics Inc., ImPACT Applications Inc., NanoDx Inc., Neuren Pharmaceuticals Limited, Advanced Brain Monitoring Inc., ElMindA Ltd., NeurOptics Inc., InfraScan Inc., Neuro Assessment Systems Inc., NeuroTrauma Sciences LLC, SyncThink Inc., Oxeia Biopharmaceuticals Inc., Oculogica Inc., Banyan Biomarkers Inc., Emotiv Inc., BioDirection Inc. 
 
 Get Your In-Depth Concussion Market Report Now:
 https://www.thebusinessresearchcompany.com/report/concussion-global-market-report
 
 Which Parts Of The World Are Emerging As High-Potential Markets For The Concussion Market?
 North America was the largest region in the concussion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the concussion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company